Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-14

Clinical Trial Update: Acetylcarnitine and Metabolic Flexibility [NA]

View source ↗

Summary

A completed clinical trial evaluated acetylcarnitine for metabolic flexibility. The study focused on individuals with glucose intolerance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetylcarnitine (acetylcarnitine)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Glucose Intolerance | NA | Status: COMPLETED